N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine

C152H174ClF5N36 — CID 158422714

IUPACN-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine
SMILESCc1cc(F)ccc1C(C)N(C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1cc(F)ccc1C(C)NC1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1cc(F)ccc1CNC1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cn1nccc1-c1nnc(N2CCC(NCc3cccc(Cl)c3)CC2)c2ccccc12
InChIInChI=1S/C27H31FN6.2C26H29FN6.C25H31FN6.C24H25ClN6.C24H29FN6/c1-18-17-20(28)9-10-22(18)19(2)32(3)21-12-15-34(16-13-21)27-24-8-6-5-7-23(24)26(30-31-27)25-11-14-29-33(25)4;1-18-16-20(27)9-8-19(18)17-31(2)21-11-14-33(15-12-21)26-23-7-5-4-6-22(23)25(29-30-26)24-10-13-28-32(24)3;1-17-16-19(27)8-9-21(17)18(2)29-20-11-14-33(15-12-20)26-23-7-5-4-6-22(23)25(30-31-26)24-10-13-28-32(24)3;1-17-15-19(26)8-7-18(17)16-30(2)20-10-13-32(14-11-20)25-22-6-4-5-21(22)24(28-29-25)23-9-12-27-31(23)3;1-30-22(9-12-27-30)23-20-7-2-3-8-21(20)24(29-28-23)31-13-10-19(11-14-31)26-16-17-5-4-6-18(25)15-17;1-16-14-18(25)7-6-17(16)15-26-19-9-12-31(13-10-19)24-21-5-3-4-20(21)23(28-29-24)22-8-11-27-30(22)2/h5-11,14,17,19,21H,12-13,15-16H2,1-4H3;4-10,13,16,21H,11-12,14-15,17H2,1-3H3;4-10,13,16,18,20,29H,11-12,14-15H2,1-3H3;7-9,12,15,20H,4-6,10-11,13-14,16H2,1-3H3;2-9,12,15,19,26H,10-11,13-14,16H2,1H3;6-8,11,14,19,26H,3-5,9-10,12-13,15H2,1-2H3
InChIKeyHARHXYPEWHCNAF-UHFFFAOYSA-N
MW2635.76 g/mol
LogP26.44
Rot. Bonds30

About N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine

N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine (PubChem CID 158422714) has the molecular formula C152H174ClF5N36 and a molecular weight of 2635.76 g/mol. Its IUPAC name is N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine.

Molecular Properties

Compound NameN-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine
PubChem CID158422714
Molecular FormulaC152H174ClF5N36
Molecular Weight2635.76 g/mol
Exact Mass2633.43
IUPAC NameN-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine
SMILESCc1cc(F)ccc1C(C)N(C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1cc(F)ccc1C(C)NC1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1cc(F)ccc1CNC1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cn1nccc1-c1nnc(N2CCC(NCc3cccc(Cl)c3)CC2)c2ccccc12
InChIInChI=1S/C27H31FN6.2C26H29FN6.C25H31FN6.C24H25ClN6.C24H29FN6/c1-18-17-20(28)9-10-22(18)19(2)32(3)21-12-15-34(16-13-21)27-24-8-6-5-7-23(24)26(30-31-27)25-11-14-29-33(25)4;1-18-16-20(27)9-8-19(18)17-31(2)21-11-14-33(15-12-21)26-23-7-5-4-6-22(23)25(29-30-26)24-10-13-28-32(24)3;1-17-16-19(27)8-9-21(17)18(2)29-20-11-14-33(15-12-20)26-23-7-5-4-6-22(23)25(30-31-26)24-10-13-28-32(24)3;1-17-15-19(26)8-7-18(17)16-30(2)20-10-13-32(14-11-20)25-22-6-4-5-21(22)24(28-29-25)23-9-12-27-31(23)3;1-30-22(9-12-27-30)23-20-7-2-3-8-21(20)24(29-28-23)31-13-10-19(11-14-31)26-16-17-5-4-6-18(25)15-17;1-16-14-18(25)7-6-17(16)15-26-19-9-12-31(13-10-19)24-21-5-3-4-20(21)23(28-29-24)22-8-11-27-30(22)2/h5-11,14,17,19,21H,12-13,15-16H2,1-4H3;4-10,13,16,21H,11-12,14-15,17H2,1-3H3;4-10,13,16,18,20,29H,11-12,14-15H2,1-3H3;7-9,12,15,20H,4-6,10-11,13-14,16H2,1-3H3;2-9,12,15,19,26H,10-11,13-14,16H2,1H3;6-8,11,14,19,26H,3-5,9-10,12-13,15H2,1-2H3
InChIKeyHARHXYPEWHCNAF-UHFFFAOYSA-N
XLogP26.44
TPSA326.85 Ų
H-Bond Donors3
H-Bond Acceptors36
Rotatable Bonds30
Heavy Atoms194
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002635.76
LogP ≤ 526.44
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1036

Analyze N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine?
The IUPAC name of N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine (CID 158422714) is N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine.
What is the SMILES notation for N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine?
The canonical SMILES for N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine is Cc1cc(F)ccc1C(C)N(C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1cc(F)ccc1C(C)NC1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.Cc1cc(F)ccc1CNC1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cn1nccc1-c1nnc(N2CCC(NCc3cccc(Cl)c3)CC2)c2ccccc12.
What is the InChIKey of N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine?
The InChIKey is HARHXYPEWHCNAF-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H31FN6.2C26H29FN6.C25H31FN6.C24H25ClN6.C24H29FN6/c1-18-17-20(28)9-10-22(18)19(2)32(3)21-12-15-34(16-13-21)27-24-8-6-5-7-23(24)26(30-31-27)25-11-14-29-33(25)4;1-18-16-20(27)9-8-19(18)17-31(2)21-11-14-33(15-12-21)26-23-7-5-4-6-22(23)25(29-30-26)24-10-13-28-32(24)3;1-17-16-19(27)8-9-21(17)18(2)29-20-11-14-33(15-12-20)26-23-7-5-4-6-22(23)25(30-31-26)24-10-13-28-32(24)3;1-17-15-19(26)8-7-18(17)16-30(2)20-10-13-32(14-11-20)25-22-6-4-5-21(22)24(28-29-25)23-9-12-27-31(23)3;1-30-22(9-12-27-30)23-20-7-2-3-8-21(20)24(29-28-23)31-13-10-19(11-14-31)26-16-17-5-4-6-18(25)15-17;1-16-14-18(25)7-6-17(16)15-26-19-9-12-31(13-10-19)24-21-5-3-4-20(21)23(28-29-24)22-8-11-27-30(22)2/h5-11,14,17,19,21H,12-13,15-16H2,1-4H3;4-10,13,16,21H,11-12,14-15,17H2,1-3H3;4-10,13,16,18,20,29H,11-12,14-15H2,1-3H3;7-9,12,15,20H,4-6,10-11,13-14,16H2,1-3H3;2-9,12,15,19,26H,10-11,13-14,16H2,1H3;6-8,11,14,19,26H,3-5,9-10,12-13,15H2,1-2H3.
What are the key properties of N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine?
N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine has a molecular weight of 2635.76 g/mol, XLogP of 26.44, 30 rotatable bonds, 3 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3-chlorophenyl)methyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[1-(4-fluoro-2-methylphenyl)ethyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine is sourced from PubChem (CID 158422714), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).